Tuesday 5th February 2019
The Royal College of Physicians, London, UK

Chairs

 

Professor Daniel Hochhauser
Professor Daniel Hochhauser
Kathleen Ferrier Professor &
Co-Director CRUK UCL
Cancer Centre
Professor John Bridgewater
Professor of Medical Oncology,
Research Department of Oncology,
UCL Cancer Institute

08.00 Registration & Coffee
09.00 Welcome / setting the scene: the Chairmen
SESSION 1: Diagnostics
09.05 Introduction – Chairman: Professor John Bridgewater
09.10 Genome sequencing in colorectal cancer
Professor Ian Tomlinson
Director of the Institute of Cancer and Genomic Sciences, The University of Birmingham, UK
09.35 New molecular diagnostics
TBC
TBC
10.00 Promises and challenges in biomarker discovery for targeted therapy
Dr Nicola Valeri
Team Leader, The Gastrointestinal Cancer Biology and Genomics Team, The Centre for Molecular Pathology, The Institute of Cancer Research, London, UK
10.25 Coffee Break
SESSION 1 contd.: Diagnostics- Chairman: Professor Daniel Hochhauser
10.50 Tracking treatment resistant cells in bowel cancers
Professor Trevor Graham
Professor of Cancer Evolution, Barts Cancer Institute, London, UK
11.15 Targeting tumour angiogenesis in cancer treatment
Professor Kairbaan Hodivala-Dilke
Professor of Angiogenesis, Deputy Institute Director, Barts Cancer Institute, London, UK
12.05 Optimising diagnosis and treatment options for CRC patients
Dr Giulia Siravegna
Postdoctoral Research Fellow, Candiolo Cancer Institute, Torino, Italy
12.45 Lunch
SESSION 2: Therapeutics
13.30 Introduction – Chairman: Professor John Bridgewater
Keynote Presentation
13.35 Emerging therapies in GI cancer
TBC
TBC
14.15 Liver metastasis from colorectal cancer
Professor John Bridgewater
Professor of Medical Oncology, Research Department of Oncology, UCL Cancer Institute, London, UK
SESSION 3: Immunotherapy
14.40 Immunotherapy in GI cancers
Professor Richard Wilson
Clinical Professor, Centre for Cancer Research and Cell Biology, Institute for Health Sciences, Queen’s University Belfast, Northern Ireland, UK
15.05 Coffee Break
SESSION 4: EGFR
15.30 Introduction – Chairman: Professor Daniel Hochhauser
15.35 EGFR therapy in Right and Left colon cancer – biological differences and clinical trials
Professor Daniel Hochhauser
Co-Director of the Cancer Research UK-UCL Centre, Kathleen Ferrier Professor & Consultant Medical Oncologist at University College London, UK
16.00 Skin toxicities of EGFR antibodies
Dr Conal Perrett
Consultant Dermatologist and Dermatological Surgeon, UCH, London
16.25 Summary & Close

Costs
The meeting costs have been underwritten by sponsors from the Pharmaceutical Industry and the event is free of charge for healthcare professionals to attend. Places are strictly limited by room capacity. As support agreements are reached, disclosure of the supporters is listed here.

This meeting is organised by:

New UCL Logo2 800

ATL-new-logo-July-2015-800px

 

and endorsed and supported by:

TLO

TL


The Frontiers of Oncology 2019 meetings are supported by the Pharmaceutical Industry.
As support agreements are reached, disclosure of the supporters is listed here.